Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, ...
Disc Medicine (IRON) announced that it has commenced an underwritten offering of $200M of shares of its common stock and, in lieu of common ...
Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic ...